Dexcom (DXCM) Free Cash Flow (2010 - 2026)

Dexcom (DXCM) has reported Free Cash Flow for 17 consecutive years, with $184.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 11.68% year-over-year to $184.5 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 146.15% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 70.79% from the prior year.
• Free Cash Flow was $184.5 million for Q2 2026 at Dexcom, down from $449.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $579.4 million in Q3 2025 and troughed at -$30.6 million in Q1 2022.
• A 5-year average of $175.4 million and a median of $164.5 million in 2024 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow plunged 59.64% in 2024 and soared 556.17% in 2025, its largest moves.
• Over 5 years, Free Cash Flow stood at $69.0 million in 2022, then grew by 17.54% to $81.1 million in 2023, then surged by 118.0% to $176.8 million in 2024, then gained by 8.65% to $192.1 million in 2025, then dropped by 3.96% to $184.5 million in 2026.
• The last three Free Cash Flow figures came in at $184.5 million (Q2 2026), $449.0 million (Q1 2026), and $192.1 million (Q4 2025), per Business Quant data.